The new oral SERDs in endocrine-resistant breast cancer: who will benefit the most?

Ann Oncol

Department of Oncology and Translational Research Unit, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy. Electronic address:

Published: August 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annonc.2024.05.542DOI Listing

Publication Analysis

Top Keywords

oral serds
4
serds endocrine-resistant
4
endocrine-resistant breast
4
breast cancer
4
cancer will
4
will benefit
4
benefit most?
4
oral
1
endocrine-resistant
1
breast
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!